Literature DB >> 2397612

Prevalence of hereditary properdin, C7 and C8 deficiencies in patients with meningococcal infections.

M Schlesinger1, Z Nave, Y Levy, P E Slater, Z Fishelson.   

Abstract

High incidence of hereditary complement (C) deficiencies was found among 101 patients who had a meningococcal disease. This study revealed 11 non-related patients with complete C deficiency: five deficient in C7, three in C8, two in properdin and one in C2. Additional C-deficient individuals, most of them with no history of severe bacterial infections, were detected in family studies. The C8-deficient patients were found to have a selective deficiency of the C8-beta subunit and a reduced expression of the alpha/gamma subunit. Only a few families with properdin deficiency have been described so far. However, it is likely that frequent analysis of the activity of the alternative C pathway in survivors of severe bacterial infections will disclose numerous properdin-deficient patients. All our C7-, C8- and properdin-deficient patients are Sephardic Jews whose families originated from Morocco, Yemen (C7 and C8 deficient) or Tunisia (properdin deficient). This and other findings indicate that the type of complement abnormality found in association with meningococcal infections varies with the ethnic origin of the patient.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2397612      PMCID: PMC1534994          DOI: 10.1111/j.1365-2249.1990.tb05350.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  30 in total

1.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

2.  Activation of the alternate pathway of human complements by rabbit cells.

Authors:  T A Platts-Mills; K Ishizaka
Journal:  J Immunol       Date:  1974-07       Impact factor: 5.422

3.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Native and activated properdin: interconvertibility and identity of amino- and carboxy-terminal sequences.

Authors:  R G Medicus; A F Esser; H N Fernandez; H J Müller-Eberhard
Journal:  J Immunol       Date:  1980-02       Impact factor: 5.422

6.  Properdin deficiency in a family with fulminant meningococcal infections.

Authors:  A G Sjöholm; J H Braconier; C Söderström
Journal:  Clin Exp Immunol       Date:  1982-11       Impact factor: 4.330

7.  Inherited deficiencies of the late-acting complement components other than C9 found among healthy blood donors.

Authors:  S Inai; Y Akagaki; T Moriyama; Y Fukumori; K Yoshimura; S Ohnoki; H Yamaguchi
Journal:  Int Arch Allergy Appl Immunol       Date:  1989

8.  Bactericidal activity of the alternative complement pathway generated from 11 isolated plasma proteins.

Authors:  R D Schreiber; D C Morrison; E R Podack; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1979-04-01       Impact factor: 14.307

9.  The membrane attack mechanism of complement: the three polypeptide chain structure of the eigth component (C8).

Authors:  W P Klob; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

10.  Assembly of the cytolytic alternative pathway of complement from 11 isolated plasma proteins.

Authors:  R D Schreiber; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1978-12-01       Impact factor: 14.307

View more
  15 in total

1.  Involvement of the ERK mitogen-activated protein kinase in cell resistance to complement-mediated lysis.

Authors:  S Kraus; R Seger; Z Fishelson
Journal:  Clin Exp Immunol       Date:  2001-03       Impact factor: 4.330

Review 2.  Molecular mechanisms of complement component C6 deficiency; a hypervariable exon 6 region responsible for three of six reported defects.

Authors:  A Orren
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

3.  An evaluation of the role of properdin in alternative pathway activation on Neisseria meningitidis and Neisseria gonorrhoeae.

Authors:  Sarika Agarwal; Viviana P Ferreira; Claudio Cortes; Michael K Pangburn; Peter A Rice; Sanjay Ram
Journal:  J Immunol       Date:  2010-06-07       Impact factor: 5.422

Review 4.  The immunopathogenesis of meningococcal disease.

Authors:  A J Kvalsvig; D J Unsworth
Journal:  J Clin Pathol       Date:  2003-06       Impact factor: 3.411

5.  Carrier detection in families with properdin deficiency by microsatellite haplotyping.

Authors:  K Kölble; A J Cant; A C Fay; K Whaley; M Schlesinger; K B Reid
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

Review 6.  Infections of people with complement deficiencies and patients who have undergone splenectomy.

Authors:  Sanjay Ram; Lisa A Lewis; Peter A Rice
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

7.  Caveolin-1 and dynamin-2 are essential for removal of the complement C5b-9 complex via endocytosis.

Authors:  Oren Moskovich; Lee-Or Herzog; Marcelo Ehrlich; Zvi Fishelson
Journal:  J Biol Chem       Date:  2012-04-23       Impact factor: 5.157

8.  Two novel mutations in the C7 gene in a Korean patient with complement C7 deficiency.

Authors:  Chang-Seok Ki; Jong-Won Kim; Hee-Jin Kim; Sung-Min Choi; Gyoung-Yim Ha; Hee Jung Kang; Won-Duck Kim
Journal:  J Korean Med Sci       Date:  2005-04       Impact factor: 2.153

9.  Inherited complement deficiency in children surviving fulminant meningococcal septic shock.

Authors:  H H Derkx; E J Kuijper; C A Fijen; M Jak; J Dankert; S J van Deventer
Journal:  Eur J Pediatr       Date:  1995-09       Impact factor: 3.183

10.  Complement component deficiencies and infection: C5, C8 and C3 deficiencies in three families.

Authors:  O Sanal; M Loos; F Ersoy; G Kanra; G Seçmeer; I Tezcan
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.